Development Level

Tbio 2 | 10,625

IMPC Phenotype

abnormal QRS complex 1 | 25
abnormal sleep behavior 1 | 63
convulsive seizures 1 | 11
decreased threshold for audito... 1 | 32
increased body length 1 | 20
increased fasted circulating g... 1 | 68

Disease

Acquired metabolic disease 2 | 267
atypical teratoid / rhabdoid tumor 2 | 4,369
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
cystic fibrosis and chronic rhinosinusitis 2 | 213
gastric carcinoma 2 | 832
glioblastoma 2 | 5,572
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,491
pancreatic cancer 2 | 2,300
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
primary pancreatic ductal adenocarcinoma 2 | 1,271
psoriasis 2 | 6,685
Allergic hypersensitivity disease 1 | 123
Allergic rhinitis 1 | 92
Allergic sensitization 1 | 4
Alopecia 1 | 55
Bladder Neoplasm 1 | 109
Breast cancer 1 | 3,098
Cardiovascular system disease 1 | 194
Cataract 1 | 104
Celiac disease 1 | 112
Chondroma 1 | 12
Cutis laxa 1 | 28
Duchenne muscular dystrophy 1 | 602
Exfoliation syndrome 1 | 8
Glaucoma 1 | 135
Globe disease 1 | 57
Iris disease 1 | 9
Juvenile arthritis 1 | 124
Kidney disease 1 | 397
Leukemia, Acute Myeloid 1 | 17
Leukemia, Myelocytic, Acute 1 | 113
Lichen planus 1 | 17
Lipoma 1 | 19
Lymphoma, Follicular 1 | 20
Pedophilia 1 | 5
Pick disease 1 | 1,893
Plague 1 | 19
Polycystic Ovary Syndrome 1 | 334
Prostate carcinoma in situ 1 | 11
VACTERL association 1 | 23
Vernal conjunctivitis 1 | 2
Vitiligo 1 | 71
acute quadriplegic myopathy 1 | 1,157
astrocytoma 1 | 1,493
chronic lymphocytic leukemia 1 | 244
colon cancer 1 | 1,475
dermatomyositis 1 | 966
fascioscapulohumeral muscular dystrophy 1 | 100
group 3 medulloblastoma 1 | 2,254
group 4 medulloblastoma 1 | 1,875
interstitial cystitis 1 | 2,299
interstitial lung disease 1 | 292
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
juvenile dermatomyositis 1 | 1,189
limb girdle muscular dystrophy 2A 1 | 156
lung adenocarcinoma 1 | 2,714
lung cancer 1 | 4,473
non primary Sjogren syndrome sicca 1 | 840
primitive neuroectodermal tumor 1 | 3,031
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis and treatment for 3 months 1 | 327
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 2 | 17,994
Cardiovascular System 2 | 17,957
Digestive Tract 2 | 18,472
Endocrine System 2 | 18,511
Female tissues 2 | 18,646
Liver and Pancreas 2 | 18,135
Male tissues 2 | 17,968
Nervous System 2 | 18,560
Respiratory system 2 | 17,483
Skin and soft tissues 2 | 18,114
Urinary Tract 2 | 18,443

Target Family

Enzyme 1 | 4,146
Non-IDG 1 | 11,969

Grant Application

5F32GM095200-02 2 | 2
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Lipoma-preferred partner LPP Tbio Non-IDG -2.72543 520.6 153
Lysyl oxidase homolog 1 LOXL1 Tbio Enzyme -2.53721 344.5 145